視源股份(002841.SZ):可轉債部分募投項目延期
格隆匯 12 月 24日丨視源股份(002841.SZ)公佈,公司於2020年12月24日召開第三屆董事會第三十三次會議和第三屆監事會第二十五次會議,會議審議通過了《關於可轉換公司債券部分募投項目延期的議案》,結合2019年公開發行可轉換公司債券募集資金投資項目目前的實施情況,同意將可轉換公司債券募投項目之“家電智能控制產品建設項目”和“人機交互技術研究中心建設項目”分別延期一年,即達到預定可使用狀態的日期統一從2021年3月31日順延至2022年3月31日。公司獨立董事與保薦機構發表了明確的同意意見。此次不涉及募投項目實施主體、實施方式或募集資金用途變更。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.